Insider · CIK 0001843393

Callori Fred

Reports to the SEC for 3 companies · BOTHELL, WA

sec.gov

Transactions

Companies

Filings

CIK

0001843393

Forms 4 and 5

Insider transactions

22 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-23	LONALeonaBio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+2,333 sh	—	—	2,333
2026-05-05	LONALeonaBio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+56K sh	—	—	56,000
2026-01-23	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14.1K sh	—	—	0
2026-01-23	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14.1K sh	—	—	0
2026-01-23	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14.2K sh	—	—	0
2026-01-23	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,333 sh	—	—	0
2026-01-23	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−26.6K sh	—	—	0
2025-06-11	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+26.6K sh	—	—	26,550
2024-06-05	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.1K sh	—	—	14,100
2024-05-23	Landos Biopharma, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,800 sh	—	—	0
2024-05-23	Landos Biopharma, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,800 sh	—	—	0
2024-05-23	Landos Biopharma, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,800 sh	—	—	0
2023-06-02	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.1K sh	—	—	14,100
2023-05-23	Landos Biopharma, Inc.Stock Option (right to buy)A Award	Director	AAward	+18K sh	—	—	18,000
2022-06-09	ATXSAstria Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,333 sh	—	—	8,333
2022-06-09	ATXSAstria Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,333 sh	—	—	8,333
2022-06-07	Landos Biopharma, Inc.Stock Option (right to buy)A Award	Director	AAward	+18K sh	—	—	18,000
2022-05-16	Landos Biopharma, Inc.Stock Option (right to buy)A Award	Director	AAward	+18K sh	—	—	18,000
2021-08-27	Landos Biopharma, Inc.Stock Option (right to buy)A Award	Director	AAward	+36K sh	—	—	36,000
2021-06-02	ATXSAstria Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+85K sh	—	—	85,000
2021-02-01	ATXSAstria Therapeutics, Inc. · Series X Convertible Preferred StockA Award	Director	AAward	+1,617 sh	$3009.53	+$4.87M	30,920
2021-01-28	ATXSAstria Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000

Recent filings

Accepted (ET)
Jun 244
Callori Fred0001843393-26-000006
SEC(opens sec.gov)
May 74
Callori Fred0001843393-26-000004
SEC(opens sec.gov)
Jan 234
Callori Fred0000905148-26-000314
SEC(opens sec.gov)
Jun 124
Callori Fred0001104659-25-058987
SEC(opens sec.gov)
Jun 64
Callori Fred0001104659-24-069072
SEC(opens sec.gov)
May 234
Callori Fred0001415889-24-014340
SEC(opens sec.gov)
Jun 64
Callori Fred0001104659-23-068338
SEC(opens sec.gov)
May 244
Callori Fred0001209191-23-031941
SEC(opens sec.gov)
Jun 214/A
Callori Fred0001104659-22-072745
SEC(opens sec.gov)
Jun 94
Callori Fred0001209191-22-035286
SEC(opens sec.gov)
Jun 94
Callori Fred0001104659-22-069753
SEC(opens sec.gov)
May 184
Callori Fred0001209191-22-030047
SEC(opens sec.gov)
Aug 314
Callori Fred0001209191-21-054058
SEC(opens sec.gov)
Jun 24
Callori Fred0001104659-21-075910
SEC(opens sec.gov)

Companies

Address

C/O LEONABIO, INC. 18706 NORTH CREEK PARKWAY, SUITE 104

BOTHELL, WA, 98011